Grab a drink, attend a talk, meet other innovators, and make things happen.
Thursday, June 20
4:30 – 5:30 p.m.
@4240 Duncan Avenue
Havana Room, 2nd Floor
The Institute of Clinical and Translational Sciences (ICTS) Precision Medicine team invites you to an on-going collaboration with Venture Café. These sessions will be hosted on the third Thursday of every month in the @4240 building.
“Designer stem cells: Genome engineering and the next generation of cell-based therapies”
Farshid Guilak, PhD, Professor of Orthopaedic Surgery, Director of Research for the Shriners Hospitals for Children
Stem cells provide tremendous promise for the development of new therapies but their translation to clinical practice has been limited. By combining recent advances in gene editing, synthetic biology, and tissue engineering, we have created new classes of “designer” cells that have prescribed sensory systems, as well as synthetic gene circuits that provide for self-regulating drug delivery or enhanced tissue repair. Dr. Guilak will show how these stem cells can then be engineered into different tissues or organs for treating various diseases, particularly arthritis and associated musculoskeletal conditions.
“Revolutionizing diabetes healthcare with organoid technology”
Jeffrey R. Millman, PhD, Assistant Professor of Medicine and Biomedical Engineering
Healthcare costs for treating diabetes is over $42 billion per year, much of which is the purchase of insulin that patients need daily. This seminar will discuss insulin-producing organoid technologies using stem cell biology and bioengineering as a revolutionary next generation treatment for patients.
For more information visit the ICTS Precision Medicine website.